Get the Stockscreener App
10.81
2.46%
0.26
After Hours:
10.81
Elanco Animal Health Inc stock is traded at $10.81, with a volume of 3.80M.
It is up +2.46% in the last 24 hours and down -1.01% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$10.55
Open:
$10.51
24h Volume:
3.80M
Relative Volume:
0.88
Market Cap:
$5.35B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
27.02
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
+2.17%
1M Performance:
-1.01%
6M Performance:
-24.51%
1Y Performance:
-33.15%
1-Day Range:
$10.51
$10.85
1-Week Range:
$10.32
$10.85
52-Week Range:
$10.03
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
2500 INNOVATION WAY, GREENFIELD
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
10.81 | 5.35B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
165.02 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.14 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.12 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.49 | 17.75B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.75 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect - Markets Insider
SEC Form DEFA14A filed by Elanco Animal Health Incorporated - Quantisnow
SEC Form DEF 14A filed by Elanco Animal Health Incorporated - Quantisnow
Form DEF 14A Elanco Animal Health For: May 16 - StreetInsider.com
Connor Clark & Lunn Investment Management Ltd. Invests $652,000 in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Prudential Financial Inc. Buys 1,214,992 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Is Elanco Animal Health Incorporated (ELAN) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Sector Gamma AS Invests $3.35 Million in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation - Markets Insider
Cannon Global Investment Management LLC Invests $454,000 in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Fox Run Management L.L.C. Acquires New Shares in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Proficio Capital Partners LLC Makes New $405,000 Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Animal Vaccines Market Projected To Witness Substantial - openPR
Veterinary Antibiotics Market Detailed In New Research Report - openPR
Elanco Animal Health Incorporated (NYSE:ELAN) Stake Raised by Magnetar Financial LLC - MarketBeat
Raymond James Financial Inc. Makes New $10.56 Million Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco to Participate in Upcoming Investor Conferences - GuruFocus.com
Peering Into Elanco Animal Health's Recent Short Interest - Benzinga
Veterinary Medicine Market Detailed In New Research Report 2025 | Ceva, Zoetis, Elanco, Chanelle Pharma Group - openPR
Here’s Why Elanco Animal Health Incorporated (ELAN) Declined in Q4 - MSN
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Primecap Management Co. CA - MarketBeat
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Animal Vaccines Market Future Business Opportunities - openPR
Animal Health Products Market Next Big Thing | Major Giants - openPR
Elanco Animal Health (ELAN): Among the Most Undervalued Biotech Stocks to Invest In - Yahoo Finance
Victory Capital Management Inc. Purchases 11,216 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Jones Financial Companies Lllp Boosts Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Fish Vaccine Market Growth in Future Scope 2025-2032 | Zoetis, Elanco, Virbac, HIPRA, Veterquímica S.A. - openPR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect - Markets Insider
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment - Yahoo Finance
Elanco Animal Health announces changes to board of directors -March 17, 2025 at 05:39 pm EDT - Marketscreener.com
Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets - PR Newswire
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by Steward Partners Investment Advisory LLC - Defense World
US Bancorp DE Has $152,000 Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Insider Buying: Elanco Animal Health Incorporated (NYSE:ELAN) Director Acquires 10,000 Shares of Stock - MarketBeat
Proficio Capital Partners LLC Invests $405,000 in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
AI-In Animal Health Market Is Booming So Rapidly | Elanco, Covetrus, Vetoquinol - openPR
Are Options Traders Betting on a Big Move in Elanco Animal Health (ELAN) Stock? - Nasdaq
Elanco Animal Health director Lawrence Kurzius buys $211,000 in stock By Investing.com - Investing.com Australia
Callan Family Office LLC Makes New Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco’s SWOT analysis: animal health stock poised for growth amid challenges - Investing.com
Elanco’s SWOT analysis: animal health stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Director Makes Bold Move with Major Stock Purchase in Elanco Animal Health - TipRanks
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):